Aytu Biopharma (AYTU) Asset Writedowns and Impairment (2020 - 2026)
Aytu Biopharma (AYTU) reported Asset Writedowns and Impairment of $400,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 95.0% from $8.06 million a year earlier and down 42.9% from the prior quarter.
Aytu Biopharma (AYTU) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma posted Asset Writedowns and Impairment of $2.2 million, down 73.4% from FY2025.
- Asset Writedowns and Impairment has a five-year compound annual growth rate of -29.7% (FY2021 to FY2026).
- By fiscal year, Asset Writedowns and Impairment came in at $8.26 million in FY2025 (+588.6%), $1.2 million in FY2024 (-79.0%), $5.71 million in FY2023 (-92.4%) and $75.46 million in FY2022 (+488.4%).
- Five-year quarterly Asset Writedowns and Impairment spans a low of $100,000 in fiscal Q2 2022 and a high of $45.2 million in fiscal Q3 2022.
- Year over year, Asset Writedowns and Impairment gained in four of the last eight quarters, with growth averaging 256.9%.
- The high point for year-over-year Asset Writedowns and Impairment in five years was fiscal Q2 2026 (growth of 700.0%); the low point was fiscal Q3 2023 (a decline of 99.8%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $700,000 (Q3 2026), $800,000 (Q2 2026) and $300,000 (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 8.06 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 10.81 Mn |
| Mar 31, 2022 | 45.20 Mn |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 19.45 Mn |
Aytu Biopharma Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AYTU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();